PepGen Inc. (PEPG)
4.565
-0.48
(-9.42%)
USD |
NASDAQ |
Nov 13, 10:26
PepGen Free Cash Flow (Quarterly) : -13.18M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -13.18M |
| June 30, 2026 | -15.84M |
| March 31, 2026 | -18.43M |
| December 31, 2025 | -15.84M |
| September 30, 2025 | -19.36M |
| June 30, 2025 | -23.64M |
| March 31, 2025 | -23.06M |
| December 31, 2024 | -19.70M |
| September 30, 2024 | -24.20M |
| June 30, 2024 | -16.38M |
| March 31, 2024 | -22.58M |
| December 31, 2023 | -19.61M |
| Date | Value |
|---|---|
| September 30, 2023 | -16.70M |
| June 30, 2023 | -18.68M |
| March 31, 2023 | -16.60M |
| December 31, 2022 | -14.49M |
| September 30, 2022 | -21.40M |
| June 30, 2022 | -13.25M |
| March 31, 2022 | -13.89M |
| December 31, 2021 | -6.142M |
| September 30, 2021 | |
| March 31, 2021 | -3.135M |
| December 31, 2020 | -0.094M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -47.06M |
| IRulya Therapeutics, Inc. | -18.89M |
| Q32 Bio, Inc. | -4.47M |
| Bridgebio Oncology Therapeutics, Inc. | -28.38M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |